Aeterna Zentaris Bumps BPH Therapy Cetrorelix To Front Of Pipeline
This article was originally published in The Pink Sheet Daily
Executive Summary
With a projected NDA filing in Q1 2010, firm plans to position the LHRH antagonist’s favorable sexual side effect profile compared to agonists such as top-selling Flomax.